SCHEMBL5459427

SCHEMBL5459427

CC1COc2c(N3CCC(C(N)CC#N)C3)c(F)cc3c(=O)[nH]c(=O)n1c23

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 6/20 0.37
KDM4E B2RXH2 5/20 0.36
AADAT Q8N5Z0 2/20 0.36
TUBB4A P04350 1/20 0.36
POLB P06746 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
SLC47A1 Q96FL8 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36
TUBB6 Q9BUF5 1/20 0.36
TUBB2B Q9BVA1 1/20 0.36
TUBB1 Q9H4B7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14444065 1.00 KCNH2 (0.37) KCNH2KDM4EAADATTUBB4APOLB
SCHEMBL14444388 0.89 KDM4E (0.35) KCNH2KDM4EAADATTUBB4APOLB
SCHEMBL5465181 0.89 KDM4E (0.35) KCNH2KDM4EAADATTUBB4APOLB
SCHEMBL14444889 0.85 AADAT (0.38) KCNH2KDM4EAADATTUBB4APOLB
SCHEMBL5459852 0.85 AADAT (0.38) KCNH2KDM4EAADATTUBB4APOLB
SCHEMBL5450712 0.81 KCNH2 (0.49) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL14443939 0.81 KCNH2 (0.49) KCNH2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5460712 0.79 KCNH2 (0.49) KCNH2KDM4EPOLBALDH1A1HPGD
SCHEMBL6529072 0.78 KDM4E (0.65) KCNH2KDM4EAADATTUBB4APOLB
SCHEMBL5454128 0.75 AADAT (0.36) KCNH2KDM4EAADATTUBB4APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US claimed
EP-1687296-A1 ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES Warner-Lambert Company LLC (US) 2006-08-09 EP claimed
WO-2005049605-A1 ANTIBACTERIAL AMINOQUINAZOLIDINEDIONE DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2005-06-02 WO claimed
US-20070191333-A1 Antibacterial agents WARNER LAMBERT COMPANY LLC 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191333-A1 Antibacterial agents MRPL21, RPN2, FBL KCNH2 2633/4885KDM4E 4500/4885AADAT 3826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.